ENSG00000130226


Homo sapiens

Features
Gene ID: ENSG00000130226
  
Biological name :DPP6
  
Synonyms : dipeptidyl peptidase like 6 / DPP6 / P42658
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 7
Strand: 1
Band: q36.2
Gene start: 153887097
Gene end: 154894285
  
Corresponding Affymetrix probe sets: 1554796_at (Human Genome U133 Plus 2.0 Array)   207789_s_at (Human Genome U133 Plus 2.0 Array)   228546_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000384393
Ensembl peptide - ENSP00000367001
Ensembl peptide - ENSP00000385578
Ensembl peptide - ENSP00000477855
Ensembl peptide - ENSP00000397303
Ensembl peptide - ENSP00000328226
NCBI entrez gene - 1804     See in Manteia.
OMIM - 126141
RefSeq - XM_017011812
RefSeq - NM_001039350
RefSeq - NM_001290252
RefSeq - NM_001290253
RefSeq - NM_001936
RefSeq - NM_130797
RefSeq - XM_017011808
RefSeq - XM_017011809
RefSeq - XM_017011810
RefSeq - XM_017011811
RefSeq Peptide - NP_001277182
RefSeq Peptide - NP_001927
RefSeq Peptide - NP_570629
RefSeq Peptide - NP_001034439
RefSeq Peptide - NP_001277181
swissprot - P42658
swissprot - E9PF59
swissprot - E9PDL2
swissprot - Q8IYG9
swissprot - A0A087WTG7
Ensembl - ENSG00000130226
  
Related genetic diseases (OMIM): 612956 - {Ventricular fibrillation, paroxysmal familial, 2}, 612956
  616311 - Mental retardation, autosomal dominant 33, 616311
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 dpp6aENSDARG00000076826Danio rerio
 dpp6bENSDARG00000024744Danio rerio
 DPP6ENSGALG00000041791Gallus gallus
 Dpp6ENSMUSG00000061576Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
DPP10 / Q8N608 / dipeptidyl peptidase like 10ENSG0000017549748
FAP / Q12884 / fibroblast activation protein alphaENSG0000007809828
DPP4 / P27487 / dipeptidyl peptidase 4ENSG0000019763528
DPP9 / Q86TI2 / dipeptidyl peptidase 9ENSG0000014200220
DPP8 / Q6V1X1 / dipeptidyl peptidase 8ENSG0000007460320


Protein motifs (from Interpro)
Interpro ID Name
 IPR001375  Peptidase S9, prolyl oligopeptidase, catalytic domain
 IPR002469  Dipeptidylpeptidase IV, N-terminal domain
 IPR029058  Alpha/Beta hydrolase fold


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006508 proteolysis IEA
 biological_processGO:0065009 regulation of molecular function IEA
 biological_processGO:0072659 protein localization to plasma membrane ISS
 biological_processGO:1901379 regulation of potassium ion transmembrane transport ISS
 cellular_componentGO:0005886 plasma membrane ISS
 cellular_componentGO:0008076 voltage-gated potassium channel complex IDA
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0016021 integral component of membrane IEA
 cellular_componentGO:0070062 extracellular exosome HDA
 molecular_functionGO:0008236 serine-type peptidase activity IEA
 molecular_functionGO:0015459 potassium channel regulator activity ISS


Pathways (from Reactome)
Pathway description
No match


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000252 Microcephaly "Microcephaly is a neurodevelopmental disorder in which the circumference of the head is more than two standard deviations smaller than the age- and gender-dependent norm." [HPO:curators]
Show

 HP:0000411 Protruding ears 
Show

 HP:0000646 Amblyopia "Reduced visual acuity that is uncorrectable by lenses in the absence of detectable anatomic defects in the eye or visual pathways. Ambylopia can result from visual deprivation during the critical period of development of visual abilities which lasts to about the age of 8 years. Thus, ambylopia can result from strabismus, anisometropia, or high hypermetropia in there is a failure to form a focused image in one or both eyes." [HPO:curators]
Show

 HP:0000666 Nystagmus, horizontal 
Show

 HP:0001137 Alternating esotropia 
Show

 HP:0001249 Mental retardation 
Show

 HP:0002650 Scoliosis "The presence of an abnormal lateral curvature of the spine." [HPO:curators]
Show

 HP:0002750 Delayed skeletal maturation "A decreased rate of skeletal maturation. Delayed skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body." [HPO:curators]
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0004325 Decreased body weight 
Show

 HP:0007018 Attention deficit hyperactivity disorder "Attention deficit hyperactivity disorder (ADHD) manifests at age 2-3 years or by first grade at the latest. The main symptoms are distractibility, impulsivity, hyperactivity, and often trouble organizing tasks and projects, difficulty going to sleep, and social problems from being aggressive, loud, or impatient." [HPO:curators]
Show

 HP:0009804 Reduced number of teeth 
Show

 HP:0200065 Choroidoretinal degeneration 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr